查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1377813

微流控免疫分析市場：按產品、技術、應用、最終用戶劃分 - 2030 年全球預測

Microfluidic Immunoassay Market by Product (Cartridge, Reagents, System), Technology (Electrochemical, Optical), Application (Cardiology, Oncology, Infectious Disease), and End User (Pharmaceutical, Hospital) - Global Forecast to 2030
出版日期: | 出版商: Meticulous Research | 英文 269 Pages | 訂單完成後即時交付

價格

微流控免疫分析市場：依產品（卡盒[聚合物、玻璃、矽膠]、試劑、系統）、依技術（電化學、光學）、依應用（心臟病學、腫瘤學、傳染病）、按最終用戶（製藥、醫院） - 世界預測到2030年

全球微流控免疫分析市場預計2030年將達到14.7億美元，2023年至2030年複合年增長率為7.4%。

經過廣泛的二次和初步研究以及對市場情景的詳細分析，本報告對關鍵行業驅動因素、限制因素、挑戰和機會進行了分析。該市場的成長是由於微流控免疫分析在藥物發現和開發以及生物標誌物檢測中的使用不斷增加、晶片實驗室免疫分析相對於傳統免疫分析的優越性以及製藥和生物技術公司對研發的越來越多的使用推動的. 更加關註生物和化學測定的小型化。然而，微流體裝置中的氣泡形成和死體積限制了該市場的成長。

此外，對現場診斷的需求不斷增長以及微流控免疫分析技術的最新進展預計將創造市場成長機會。然而，新興國家微流控晶片設計中合適的基板材料和產品設計的選擇以及成本相關的限制給市場利益相關者帶來了重大挑戰。

該報告基於對產品組合、區域影響力以及行業領先市場參與者多年來（2020-2023）採用的關鍵策略發展的廣泛評估，提供了競爭格局。全球微流控免疫分析市場的主要公司有Becton, Dickinson and Company（美國）、Revvity, Inc.（美國）、Abbott Laboratories（美國）、Siemens Healthineers AG（德國）、Nanomix Corporation（美國）、Micropoint Biotechnologies Co.（中國）、Biosurfit SA（葡萄牙）、Koninklijke Philips NV（荷蘭）、NanoEnTek Inc.（韓國）和 QuidelOrtho Corporation（美國）。

在本報告研究的所有產品中，耗材領域預計將在 2023 年佔據微流控免疫分析市場的最大份額。此細分市場的巨大市場份額歸因於試劑盒的重複使用、用於疾病早期診斷的特定疾病試劑盒組合的增加以及產品批准的增加。試劑和試劑盒的不斷進步、用戶友好的診斷試劑盒的開發以及臨床和研究實驗室中微流控免疫分析盒的採用正在對微流控耗材的需求產生積極影響。

在本報告調查的技術中，電化學檢測領域預計在預測期內複合年增長率最高。電化學檢測因其成本低、省電、樣品和試劑消耗低、便攜性以及響應時間短等優點而越來越多地應用於微流控免疫分析，推動了該領域最高的複合年增長率，這也是其昂貴的因素。

在本報告研究的所有應用中，預計心血管領域將在2023年佔據微流控免疫分析市場的最大份額。該領域的巨大市場份額歸因於微流控盒在心血管疾病生物標記分析和疾病機制闡明中的應用不斷增加。心臟生物標記研究的生物醫學和臨床領域對微流控免疫分析的需求不斷增加，佔據了最大的市場份額。

在本報告研究的所有最終用戶中，製藥和生技公司領域預計在預測期內將以最高的複合年增長率成長。此細分市場複合年增長率最高的原因是製藥和生物技術公司增加研發投資、微流控免疫分析在藥物發現研發中的廣泛使用以及對個人化醫療研究的日益重視等因素。製藥公司不斷增加的研發支出也貢獻了該細分市場的最大份額。

對全球微流控免疫分析市場區域狀況的詳細分析為五個關鍵地區（北美、歐洲、亞太地區、拉丁美洲、中東和非洲）以及每個地區的主要國家提供了深入的定性和定量見解。地區。提供覆蓋範圍。2023年，北美預計將佔據微流控免疫分析市場的最大份額，其次是歐洲、亞太地區、拉丁美洲以及中東和非洲。北美的高份額是由於製藥和生物技術公司識別藥物和生物標誌物的研發成本較高、慢性病患病率上升以及醫療保健支出不斷增加。這是由於該地區存在強大的市場參與者以及政府的有利措施研究與開發。根據國會預算辦公室預測，美國藥物研發支出將從2020年的911億美元增加到2021年的1,023億美元。

研究範圍：

微流控免疫分析市場評估（分產品）

  • 消耗品
  • 墨盒
    • 聚合物
    • 玻璃
    • 矽
  • 試劑
  • 系統

微流控免疫分析市場評估（按技術）

  • 電化學檢測
  • 光學檢測

微流控免疫分析市場評估：依應用分類

  • 心臟病學
  • 單一生物標記檢測
  • 多重生物標記檢測
  • 感染
  • 腫瘤學
  • 其他應用

注意：其他應用包括懷孕、糖尿病、甲狀腺、腎臟疾病和藥物濫用測試。

微流控免疫分析市場評估（按最終用戶）

  • 製藥和生物技術公司
  • 診斷實驗室
  • 醫院
  • 其他最終用戶

註：其他最終使用者包括家庭醫療保健、自我檢測、學術機構/研究中心、法醫實驗室等。

微流控免疫分析市場評估（按地區）

  • 北美
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 法國
  • 意大利
  • 西班牙
  • 其他歐洲 (RoE)
  • 亞太地區 (APAC)
  • 中國
  • 日本
  • 印度
  • 其他亞太地區 (RoAPAC)
  • 拉丁美洲
  • 中東/非洲

目錄

第 1 章 簡介

第二章研究方法論

第三章執行摘要

第四章市場洞察

  • 市場
  • 概述
  • 影響市場成長的因素
    • 市場動態影響分析
      • 在藥物發現/市場開發和生物標記檢測中越來越多地使用微流控免疫分析來推動市場成長
      • 氣泡的形成和死體積限制了微流體裝置的採用
      • 對現場檢測的需求不斷增長為市場參與者創造了成長機會
      • 為微流控晶片設計選擇合適的基板材料仍然是市場參與者面臨的關鍵挑戰
    • 因子分析
  • 技術趨勢
    • 多重面板偵測
    • 紙基微流體
  • 監管分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
    • 亞太地區
      • 中國
      • 日本
      • 印度
    • 拉丁美洲
    • 中東
      • 沙特阿拉伯
  • 價格分析
  • 波特五力分析

第五章微流控免疫分析市場產品評估

  • 概述
  • 消耗品
    • 墨盒
      • 聚合物
      • 玻璃
      • 矽
    • 試劑
  • 系統

第六章 微流體免疫分析技術市場評價

  • 概述
  • 電化學檢測
  • 光學檢測

第七章微流控免疫分析市場的應用評估

  • 概述
  • 心臟病學
    • 單一生物標記檢測
    • 多重生物標記檢測
  • 感染
  • 腫瘤學
  • 其他應用

第八章最終用戶的微流控免疫分析市場評估

  • 概述
  • 製藥和生物技術公司
  • 診斷實驗室
  • 醫院
  • 其他最終用戶

第九章微流控免疫分析市場的區域評估

  • 概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太其他地區
  • 拉丁美洲
  • 中東/非洲

第 10 章 競爭分析

  • 概述
  • 主要成長策略
  • 競爭標桿
  • 比賽儀表板
    • 產業領導者
    • 差異化因素
    • 先鋒隊
    • 啟動

第十一章 公司簡介（公司概況、財務概況、產品組合、策略發展）

  • Abbott Laboratories
  • Revvity, Inc.（Formerly PerkinElmer, Inc.）
  • Siemens Healthineers AG.
  • QuidelOrtho Corporation.
  • Nanomix, Inc.
  • Becton, Dickinson and Company
  • Micropoint Biotechnologies Co., Ltd.
  • Biosurfit SA
  • Koninklijke Philips N.V.
  • NanoEnTek Inc.

（註：我們提供了前 5 名公司的 SWOT 分析。）

第十二章附錄

Product Code: MRHC - 104334

Microfluidic Immunoassay Market by Product (Cartridge [Polymer, Glass, Silicon], Reagents, System), Technology (Electrochemical, Optical), Application (Cardiology, Oncology, Infectious Disease), and End User (Pharmaceutical, Hospital)-Global Forecast to 2030

The global microfluidic immunoassay market is expected to reach $1.47 billion by 2030 at a CAGR of 7.4% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of this market is driven by the increasing use of microfluidic immunoassays in drug discovery & development and biomarker detection, the advantages of lab-on-chip immunoassays over conventional immunoassays, pharmaceutical & biotechnology companies' increasing focus on research & development, and the miniaturization of biological and chemical assays. However, bubble formation and dead volume in microfluidics devices restrain the growth of this market.

Moreover, the increasing demand for point-of-care diagnostics and recent advancements in microfluidic immunoassay technology are expected to generate market growth opportunities. However, the selection of suitable substrate materials for designing microfluidic chips and product design and cost-related limitations in developing countries are major challenges for market stakeholders.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the years (2020-2023). The key players operating in the global microfluidic immunoassay market are Becton, Dickinson and Company (U.S.), Revvity, Inc. (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Nanomix Corporation (U.S.), Micropoint Biotechnologies Co., Ltd. (China), Biosurfit SA (Portugal), Koninklijke Philips N.V. (Netherland), NanoEnTek Inc. (South Korea), and QuidelOrtho Corporation (U.S.).

Among all the products studied in this report, in 2023, the consumables segment is expected to account for the largest share of the microfluidic immunoassay market. The large market share of this segment is attributed to the repetitive use of kits, the growing portfolio of disease-specific kits for early diagnosis of diseases, and the increasing product approvals. The continuous advancements in reagents and kits, the development of user-friendly diagnostic kits, and the adoption of microfluidic immunoassay cartridges in clinical and research laboratories are positively impacting the demand for consumables used in microfluidics.

Among all the technologies studied in this report, the electrochemical detection segment is projected to register the highest CAGR during the forecast period. Electrochemical detection is increasingly used in the microfluidic immunoassay owing to benefits such as low cost & power requirements, low sample & reagent consumption, portability, and short response time, contributing to the highest CAGR of this segment.

Among all the applications studied in this report, in 2023, the cardiology segment is expected to account for the largest share of the microfluidic immunoassay market. The large market share of this segment is attributed to increasing applications of microfluidic cartridges in biomarker profiling of cardiovascular diseases and understanding disease mechanisms. The demand for microfluidic immunoassay is increasing in biomedical and clinical fields for research on cardiac biomarkers, contributing to the largest share of the market.

Among all the end users studied in this report, the pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period. The highest CAGR of this segment is attributed to factors such as the increasing R&D investments by pharmaceutical & biotechnology companies, the widespread utilization of microfluidic immunoassay in drug discovery & development, and a growing emphasis on personalized medicine research. The rising spending on R&D by pharmaceutical companies is also contributing to the largest share of this segment.

An in-depth analysis of the geographical scenario of the global microfluidic immunoassay market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the microfluidic immunoassay market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America's large share is attributed to the region's high R&D spending by the pharmaceutical & biotechnology companies for the development of drugs and biomarker identification, increasing prevalence of chronic diseases, rising healthcare expenditure, presence of leading market players in the region, and favorable government initiatives for research & development. According to the U.S. Congressional Budget Office, U.S. pharmaceutical R&D expenditure increased from USD 91.1 billion in 2020 to USD 102.3 billion in 2021.

Scope of the Report:

Microfluidic Immunoassay Market Assessment, by Product

  • Consumables
  • Cartridges
    • Polymer
    • Glass
    • Silicon
  • Reagents
  • Systems

Microfluidic Immunoassay Market Assessment, by Technology

  • Electrochemical Detection
  • Optical Detection

Microfluidic Immunoassay Market Assessment, by Application

  • Cardiology
  • Single Biomarker Detection
  • Multiplexed Biomarker Detection
  • Infectious Diseases
  • Oncology
  • Other Applications

Note: Other applications consist of pregnancy, diabetes, thyroid, kidney diseases, and drug of abuse testing

Microfluidic Immunoassay Market Assessment, by End User

  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Hospital
  • Other End Users

Note: Other end users include home healthcare, self-testing, academic institutes & research centers, and forensic labs.

Microfluidic Immunoassay Market Assessment, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
      • 4.2.1.1. Increasing Use of Microfluidic Immunoassays in Drug Discovery & Development and Biomarker Detection Driving Market Growth
      • 4.2.1.2. Bubble Formation and Dead Volume Limiting the Adoption of Microfluidics Devices
      • 4.2.1.3. Increasing Demand for Point-of-Care Testing Generating Growth Opportunities for Market Players
      • 4.2.1.4. Selecting Suitable Substrate Materials to Design Microfluidic Chips to Remain a Major Challenge for Market Players
    • 4.2.2. Factor Analysis
  • 4.3. Technology Trends
    • 4.3.1. Multiplexed Panel Detection
    • 4.3.2. Paper-Based Microfluidics
  • 4.4. Regulatory Analysis
    • 4.4.1. North America
      • 4.4.1.1. U.S.
      • 4.4.1.2. Canada
    • 4.4.2. Europe
    • 4.4.3. Asia-Pacific
      • 4.4.3.1. China
      • 4.4.3.2. Japan
      • 4.4.3.3. India
    • 4.4.4. Latin America
    • 4.4.5. Middle East
      • 4.4.5.1. Saudi Arabia
  • 4.5. Pricing Analysis
  • 4.6. Porter's Five Forces Analysis
    • 4.6.1. Bargaining Power of Suppliers
    • 4.6.2. Bargaining Power of Buyers
    • 4.6.3. Threat of Substitutes
    • 4.6.4. Threat of New Entrants
    • 4.6.5. Degree of Competition

5. Microfluidic Immunoassay Market Assessment-by Product

  • 5.1. Overview
  • 5.2. Consumables
    • 5.2.1. Cartridges
      • 5.2.1.1. Polymer
      • 5.2.1.2. Glass
      • 5.2.1.3. Silicon
    • 5.2.2. Reagents
  • 5.3. Systems

6. Microfluidic Immunoassay Market Assessment-by Technology

  • 6.1. Overview
  • 6.2. Electrochemical Detection
  • 6.3. Optical Detection

7. Microfluidic Immunoassay Market Assessment-by Application

  • 7.1. Overview
  • 7.2. Cardiology
    • 7.2.1. Single Biomarker Detection
    • 7.2.2. Multiplexed Biomarker Detection
  • 7.3. Infectious Diseases
  • 7.4. Oncology
  • 7.5. Other Applications

8. Microfluidic Immunoassay Market Assessment-by End User

  • 8.1. Overview
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Diagnostic Laboratories
  • 8.4. Hospital
  • 8.5. Other End Users

9. Microfluidic Immunoassay Market Assessment-by Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific
  • 9.5. Latin America
  • 9.6. Middle East & Africa

10. Competition Analysis

  • 10.1. Overview
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies

11. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)

  • 11.1. Abbott Laboratories
  • 11.2. Revvity, Inc. (Formerly PerkinElmer, Inc.)
  • 11.3. Siemens Healthineers AG.
  • 11.4. QuidelOrtho Corporation.
  • 11.5. Nanomix, Inc.
  • 11.6. Becton, Dickinson and Company
  • 11.7. Micropoint Biotechnologies Co., Ltd.
  • 11.8. Biosurfit SA
  • 11.9. Koninklijke Philips N.V.
  • 11.10. NanoEnTek Inc.

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports

List of Tables

  • Table 1 Funding for Microfluidic Immunoassay Research & Development
  • Table 2 Estimated Number of New Cancer Cases, by Type (2020 Vs. 2030)
  • Table 3 Research Studies on Paper-Based Microfluidics, 2017-2023
  • Table 4 Authorities Regulating In Vitro Diagnostic Products, by Country/Region
  • Table 5 Medical Devices Regulatory Authorities in the Rest of APAC Countries
  • Table 6 Average Selling Prices of Microfluidic Immunoassay Products (USD/Unit)
  • Table 7 Quidelortho Corporation (U.S.): Product Pricing (USD/Unit)
  • Table 8 Abbott Laboratories (U.S.): Product Pricing (USD/Unit)
  • Table 9 Global Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 10 Global Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 11 Global Microfluidic Immunoassay Consumables Market, by Country/Region, 2021-2030 (USD Million)
  • Table 12 Global Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 13 Global Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021-2030 (USD Million)
  • Table 14 Global Polymer-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021-2030 (USD Million)
  • Table 15 Global Glass-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021-2030 (USD Million)
  • Table 16 Global Silicon-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021-2030 (USD Million)
  • Table 17 Global Microfluidic Immunoassay Reagents Market, by Country/Region, 2021-2030 (USD Million)
  • Table 18 Global Microfluidic Immunoassay Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 19 Global Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 20 Global Microfluidic Immunoassay Market for Electrochemical Detection, by Country/Region, 2021-2030 (USD Million)
  • Table 21 Optical Detection Techniques for Microfluidic Applications
  • Table 22 Global Microfluidic Immunoassay Market for Optical Detection, by Country/Region, 2021-2030 (USD Million)
  • Table 23 Global Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 24 Clinically Significant Cardiac Biomarkers
  • Table 25 Global Microfluidic Immunoassay Market for Cardiology, by Type, 2021 2030 (USD Million)
  • Table 26 Global Microfluidic Immunoassay Market for Cardiology, by Country/Region, 2021-2030 (USD Million)
  • Table 27 Commercially Available Tests for Single Cardiac Biomarker Detection
  • Table 28 Global Microfluidic Immunoassay Market for Single Biomarker Detection, by Country/Region, 2021-2030 (USD Million)
  • Table 29 Commercially Available Tests for Multiplexed Cardiac Biomarker Detection
  • Table 30 Global Microfluidic Immunoassay Market for Multiplexed Biomarker Detection, by Country/Region, 2021-2030 (USD Million)
  • Table 31 Global Microfluidic Immunoassay Market for Infectious Disease, by Country/Region, 2021-2030 (USD Million)
  • Table 32 Clinically Significant Oncology Biomarkers
  • Table 33 Global Microfluidic Immunoassay Market for Oncology, by Country/Region, 2021-2030 (USD Million)
  • Table 34 Commercially Available Tests for Diabetes Biomarker Detection
  • Table 35 Global Microfluidic Immunoassay Market for Other Applications, by Country/Region, 2021-2030 (USD Million)
  • Table 36 Global Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 37 Global Microfluidic Immunoassay Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021-2030 (USD Million)
  • Table 38 Global Microfluidic Immunoassay Market for Diagnostic Laboratories, by Country/Region, 2021-2030 (USD Million)
  • Table 39 Global Microfluidic Immunoassay Market for Hospitals, by Country/Region, 2021-2030 (USD Million)
  • Table 40 Global Microfluidic Immunoassay Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
  • Table 41 Global Microfluidic Immunoassay Market, by Country/Region, 2021-2030 (USD Million)
  • Table 42 North America: Microfluidic Immunoassay Market, by Country, 2021-2030 (USD Million)
  • Table 43 North America: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 44 North America: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 45 North America: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 46 North America: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 47 North America: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 48 North America: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 49 North America: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 50 U.S.: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 51 U.S.: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 52 U.S.: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 53 U.S.: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 54 U.S.: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 55 U.S.: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 56 U.S.: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 57 Canada: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 58 Canada: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 59 Canada: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 60 Canada: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 61 Canada: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 62 Canada: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 63 Canada: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 64 Europe: Microfluidic Immunoassay Market, by Country/Region, 2021-2030 (USD Million
  • Table 65 Europe: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 66 Europe: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 67 Europe: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 68 Europe: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 69 Europe: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 70 Europe: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 71 Europe: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 72 Germany: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 73 Germany: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 74 Germany: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 75 Germany: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million
  • Table 76 Germany: Microfluidic Immunoassay Market, by Application, 2021-2030(USD Million)
  • Table 77 Germany: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 78 Germany: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 79 France: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 80 France: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 81 France: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 82 France: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 83 France: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 84 France: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 85 France: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 86 U.K.: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 87 U.K.: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 88 U.K.: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 89 U.K.: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 90 U.K.: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 91 U.K.: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 92 U.K.: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 93 Italy: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 94 Italy: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 95 Italy: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 96 Italy: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 97 Italy: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 98 Italy: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 99 Spain: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 100 Spain: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 101 Spain: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 102 Spain: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 103 Spain: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 104 Spain: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 105 Spain: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 106 Covid-19 Cases in European Countries
  • Table 107 Rest of Europe: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 108 Rest of Europe: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 109 Rest of Europe: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 110 Rest of Europe: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 111 Rest of Europe: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 112 Rest of Europe: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 113 Rest of Europe: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 114 Asia-Pacific: Microfluidic Immunoassay Market, by Country/Region, 2021-2030 (USD Million)
  • Table 115 Asia-Pacific: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 116 Asia-Pacific: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 117 Asia-Pacific: Microfluidic Immunoassay Cartridges Market, by Material,2021-2030 (USD Million)
  • Table 118 Asia-Pacific: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 119 Asia-Pacific: Microfluidic Immunoassay Market, by Application, 2021-2030(USD Million)
  • Table 120 Asia-Pacific: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 121 Asia-Pacific: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 122 China: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 123 China: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 124 China: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 125 China: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 126 China: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 127 China: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 128 China: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 129 Japan: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 130 Japan: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 131 Japan: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 132 Japan: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 133 Japan: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 134 Japan: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 135 Japan: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 136 India: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 137 India: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 138 India: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 139 India: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 140 India: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 141 India: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 142 India: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 143 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 144 Rest of Asia-Pacific: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 145 Rest of Asia-Pacific: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 146 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 147 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 148 Rest of Asia-Pacific: Microfluidic Immunoassay Market for Cardiology, by Type, 2021 2030 (USD Million)
  • Table 149 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 150 Latin America: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 151 Latin America: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 152 Latin America: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 153 Latin America: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 154 Latin America: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 155 Latin America: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 156 Latin America: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 157 Saudi Arabia, South Africa, and UAE Estimated Cancer Incidence
  • Table 158 Middle East & Africa: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 159 Middle East & Africa: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 160 Middle East & Africa: Microfluidic Immunoassay Cartridges Market, by Material, 2021 2030 (USD Million)
  • Table 161 Middle East & Africa: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 162 Middle East & Africa: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 163 Middle East & Africa: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 164 Middle East & Africa: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 165 Recent Developments, by Company, 2020-2023